Corcept Therapeutics, Inc. (CORT)
34.82
+0.58
(+1.69%)
USD |
NASDAQ |
Feb 20, 16:00
34.60
-0.22
(-0.63%)
After-Hours: 20:00
Corcept Therapeutics SG&A Expense (Quarterly) : 123.98M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Axsome Therapeutics, Inc. | 150.24M |
| United Therapeutics Corp. | 152.00M |
| Harrow, Inc. | 35.86M |
| Ultragenyx Pharmaceutical, Inc. | 89.00M |
| Amneal Pharmaceuticals, Inc. | 137.82M |